AGRENVEC joints the biotechnology with the agrarian engineering to use the plants as biofactories, obtaining as final product enzymes for biomedical and industrial use. AGRENVEC is also developing new molecules with therapeutic and diagnosis potential in cancer, specially suitable to be produced industrially in plants.

Our technology is based in the use of ADN vectors, being the only spanish company able to develop this production system.

This technology is cheaper, safer, more productive, more flexible and faster than any other proteins production system. AGRENVEC can produce proteins with the required degree of purity and in any amount, from micrograms to kilograms.

Due to this system, the times of production are reduced between 50% and 90% compared to other industrial production of proteins processes.